NDC 58160-964

RabAvert

Rabies Vaccine

RabAvert is a Kit in the Vaccine category. It is labeled and distributed by Glaxosmithkline Biologicals Sa. The primary component is .

Product ID58160-964_6aaf45e1-7af5-4d94-be4f-72eeadc2e0d9
NDC58160-964
Product TypeVaccine
Proprietary NameRabAvert
Generic NameRabies Vaccine
Dosage FormKit
Marketing Start Date2016-12-19
Marketing End Date2024-01-31
Marketing CategoryBLA / BLA
Application NumberBLA103334
Labeler NameGlaxoSmithKline Biologicals SA
Active Ingredient Strength0
NDC Exclude FlagN

Packaging

NDC 58160-964-12

1 KIT in 1 CARTON (58160-964-12) * 1 mL in 1 VIAL, GLASS (58160-966-01) * 1 mL in 1 SYRINGE (58160-967-02)
Marketing Start Date2016-12-19
Marketing End Date2024-01-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 58160-964-12 [58160096412]

RabAvert KIT
Marketing CategoryBLA
Application NumberBLA103334
Product TypeVACCINE
Billing UnitEA
Marketing Start Date2016-12-19

Drug Details

NDC Crossover Matching brand name "RabAvert" or generic name "Rabies Vaccine"

NDCBrand NameGeneric Name
50090-1820RabAvertRabies Vaccine
50090-3096RabAvertRabies Vaccine
50632-010RabAvertRabies Vaccine
58160-964RabAvertRabies Vaccine
63851-501RabAvertRabies Vaccine

Trademark Results [RabAvert]

Mark Image

Registration | Serial
Company
Trademark
Application Date
RABAVERT
RABAVERT
79301264 not registered Live/Pending
BAVARIAN NORDIC A/S
2020-10-16
RABAVERT
RABAVERT
75172869 2200256 Live/Registered
GSK VACCINES GMBH
1996-09-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.